Pipeline

Product Indication Research IND Enabling Phase 1 Phase 2 Phase 3
AKST/GRF 6019/6021
Alzheimer’s Disease – Mild to Moderate
AKST/GRF 6019/6021 Alzheimer’s Disease – Mild to Moderate
Alzheimer’s Disease – Advanced
Alzheimer’s Disease – Advanced
Parkinson’s Disease
Parkinson’s Disease
Undisclosed Disease
Undisclosed Disease
AKST4290
WetAMD
AKST4290 WetAMD
Neurodegenerative Disease
Neurodegenerative Disease
Neurodegenerative Disease
Inflammatory Disease
AKST1210
Dialysis Related Dementia
AKST1210 Dialysis Related Dementia
Novel Factors
Novel Factors